• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Inspire Medical Systems Invests in AI Startup EnsoData

by Fred Pennic 04/29/2022 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
Inspire Medical Systems Invests in AI Startup EnsoData

What You Should Know:

– Inspire Medical Systems has announced its investment in EnsoData, an artificial intelligence (AI) healthcare company helping clinicians uncover disease while patients sleep. 

– EnsoData’s technology helps address some of the most intractable problems in healthcare: access and affordability for patients and clinician burnout. By letting doctors and other clinicians use powerful AI to automatically analyze and diagnose diseases while a patient sleeps, EnsoData unlocks more rapid, accurate, and affordable diagnosis and therapy for diseases that plague millions of people – like OSA. 

– Over 20 million Americans have OSA, and many go undiagnosed or untreated due to limited capacity for specialty sleep care. This partnership will play an important role in increasing sleep practice capacity to address this growing health challenge. 


Empowering Clinicians with Waveform AI

EnsoData increases sleep lab capacity and efficiency with their FDA-approved sleep study analysis platform, EnsoSleep. Using waveform Artificial Intelligence (AI), EnsoSleep automates the scoring and analysis of polysomnography (PSG) and home sleep testing, freeing clinician time to focus on patients. Further, EnsoSleep analyzes sleep test waveform data to provide accurate sleep staging and event detection for clinician review. The technology integrates with the sleep labs’ existing software and diagnostic devices, automatically analyzes and scores sleep studies, and requires no change to existing clinical workflows. EnsoSleep is currently available in over 500 sleep centers in the U.S. and analyzes over 30,000 sleep studies per month. Inspire’s minority investment in EnsoData is $10 million.

Ognomy was built by sleep physicians to increase access to sleep apnea care by shifting diagnosis and treatment from the clinic to patients’ homes. The Ognomy app provides the interface between the patient and a sleep physician, while the Ognomy web portal allows clinicians to see and manage patients from any location. Following a digital consultation, the physician can order a home sleep study to be sent directly to the patient. Typically, the patient can receive a completed sleep evaluation and clinician follow-up in just a few days. Inspire provided seed funding to Ognomy to further develop their platform and to initiate a pilot program intended to support its integration with the Inspire Advisor Care Program starting in May of 2022.

“These partnerships emphasize our focus on developing a digital platform to help patients navigate their journey to an effective solution for their OSA, such as Inspire therapy,” stated Tim Herbert, Inspire Medical Systems President & CEO. “As we expand our Advisor Care Program, we understand that long sleep study wait times are a challenge for many patients. We need innovative solutions to help patients quickly, conveniently, and accurately assess the severity of their OSA and subsequently connect appropriate patients with a qualified healthcare provider to consider treatment options, including Inspire therapy. These investments will allow EnsoData and Ognomy to more rapidly grow their respective businesses, which will benefit Inspire’s ability to more broadly leverage their technologies.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: AI, Artificial Intelligence, clinical workflows, FDA, physicians, Portal, sleep apnea

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |